| COLL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the COLL shares outstanding history going back to 5/6/2015:
Also see: COLL Market Cap History COLL YTD Return |
| COLL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COLL Historical Shares Outstanding: +4.54% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| COLL Stock Price Chart |
| About Collegium Pharmaceutical Inc |
| Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. Co. commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the U.S.. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed with abuse deterrent properties and uses a technology platform, DETERx. The Nucynta Products are ER and IR oral formulations of tapentadol. Nucynta ER is indicated for the management of severe and persistent pain that requires an extended treatment period with a daily opioid analgesic. We show 46 historical shares outstanding datapoints in our coverage of COLL's shares outstanding history. Understanding the changing numbers of COLL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like COLL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching COLL by allowing them to research COLL shares outstanding history as well as any other stock in our coverage universe. |
| COLL Current Stock Quote |
Quotes delayed 20 minutes  Free COLL Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| COLL Share Performance |
| Shares Outstanding Peers |
| Collegium Pharmaceuticals (COLL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
COM Shares Outstanding History CON Shares Outstanding History COO Shares Outstanding History COOL Shares Outstanding History COR Shares Outstanding History CORI Shares Outstanding History CORT Shares Outstanding History COSM Shares Outstanding History COT Shares Outstanding History COYA Shares Outstanding History More Healthcare companies » |
COLL Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
